Cargando…
Damoctocog Alfa Pegol: A Review in Haemophilia A
Damoctocog alfa pegol (Jivi(®)) is approved in the USA, EU, Japan and Canada for the treatment and prophylaxis of previously treated patients aged ≥ 12 years with haemophilia A. Formulated with a 60 kDa polyethylene glycol (PEG) moiety, damoctocog alfa pegol is an intravenously (IV) administered rec...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711950/ https://www.ncbi.nlm.nih.gov/pubmed/31218660 http://dx.doi.org/10.1007/s40265-019-01152-7 |